MARKET

MURA

MURA

Mural Oncology PLC
NASDAQ
2.560
-0.100
-3.76%
After Hours: 2.570 +0.01 +0.39% 19:54 05/14 EDT
OPEN
2.690
PREV CLOSE
2.660
HIGH
2.690
LOW
2.560
VOLUME
75.97K
TURNOVER
--
52 WEEK HIGH
4.740
52 WEEK LOW
0.9500
MARKET CAP
44.21M
P/E (TTM)
-0.3377
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at MURA last week (0505-0509)?
Weekly Report · 2d ago
Weekly Report: what happened at MURA last week (0428-0502)?
Weekly Report · 05/05 12:25
FORM 8.1(a) & (b) - Mural Oncology plc
Barchart · 04/30 14:07
Weekly Report: what happened at MURA last week (0421-0425)?
Weekly Report · 04/28 12:40
Largest borrow rate increases among liquid names
TipRanks · 04/22 12:45
Unusually active option classes on open April 21st
TipRanks · 04/21 13:40
Weekly Report: what happened at MURA last week (0414-0418)?
Weekly Report · 04/21 12:39
MURA Soars as it Explores Strategic Options Post Cancer Study Failures
NASDAQ · 04/16 13:48
More
About MURA
More
Mural Oncology plc is Ireland-based clinical-stage oncology company. The Company is leveraging its protein engineering platform to develop cytokine-based immunotherapies for the treatment of cancer. It leverages its in-cytokine biology, immune cell modulation and protein engineering capabilities to develop immunotherapies. The Company is developing a portfolio of programs to broaden the potential and reach of cytokine-based immunotherapies for the treatment of cancers, particularly those with limited treatment options available. Its portfolio of programs includes Nemvaleukin alfa (Nemvaleukin)-IL-2, IL-12, and IL-18. Nemvaleukin is an engineered interleukin-2 (IL-2) variant designed to harness the potent anti-cancer capabilities of high-dose rhIL-2 while minimizing toxicity by selectively activating cancer-fighting CD8 T cells and NK cells. The tumor-targeted split IL-12 program focuses on delivering the therapeutic potential of IL-12 by splitting it into inactive component.
Recently
Symbol
Price
%Change

Webull offers Mural Oncology PLC stock information, including NASDAQ: MURA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MURA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MURA stock methods without spending real money on the virtual paper trading platform.